AHB-US
AHB-US, also known as AHB, is a prominent player in the biotechnology industry, headquartered in the United States. Founded in 2010, the company has established itself as a leader in the development of innovative biopharmaceuticals and advanced therapeutic solutions, primarily focusing on areas such as regenerative medicine and cellular therapies. With a strong operational presence across North America and Europe, AHB-US is renowned for its cutting-edge products, including proprietary cell culture systems and biologics. These offerings are distinguished by their high efficacy and safety profiles, setting new standards in the industry. Recognised for its commitment to research and development, AHB-US has achieved significant milestones, including numerous patents and collaborations with leading research institutions. This positions the company as a key contributor to advancements in biotechnology, making it a trusted partner in the healthcare sector.
DitchCarbon Score
How does AHB-US's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AHB-US's score of 16 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AHB-US's reported carbon emissions
In 2023, AHB-US reported total carbon emissions of approximately 138,205,720 kg CO2e. This figure includes 37,146,460 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 100,958,680 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, Scope 3 emissions accounted for about 100,580 kg CO2e, which encompass all other indirect emissions not included in Scope 2. Currently, AHB-US has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. As such, their climate commitments remain unclear, and there are no documented pledges or targets under the Science Based Targets initiative (SBTi) or other frameworks. This lack of defined goals may place AHB-US in a challenging position within the industry, as many organisations are increasingly setting ambitious climate targets to mitigate their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 37,146,460 |
| Scope 2 | 100,958,680 |
| Scope 3 | 100,580 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AHB-US is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
